These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 262711)

  • 41. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunologic evaluation of measles vaccine in preschool and school children].
    Soto C; Cordero J; Vergara MI
    Rev Chil Pediatr; 1981; 52(6):491-5. PubMed ID: 7347862
    [No Abstract]   [Full Text] [Related]  

  • 44. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres.
    Bhatnagar SK; Mohan M; Kumar P; Balaya S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):625-9. PubMed ID: 6797943
    [No Abstract]   [Full Text] [Related]  

  • 45. [Postvaccinal measles immunity characteristics of Leningrad children].
    Smorodinova IP; Zubov AK; Sobolevskaia AA; Kaplan AS; Smordintsev AA
    Tr Inst Im Pastera; 1979; 53():66-70. PubMed ID: 162464
    [No Abstract]   [Full Text] [Related]  

  • 46. [Duration of the preservation of postvaccinal immunity against measles and the results of a repeat immunization of children with various initial antibody levels].
    Sokhin AA; Sliusar' LI; Popov VF; Noskov FS; Radomskaia FS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):79-85. PubMed ID: 6637278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus.
    Aleksandrowicz J; Polna I; Sadowski W
    Acta Microbiol Pol A; 1973; 5(3):139-45. PubMed ID: 4203633
    [No Abstract]   [Full Text] [Related]  

  • 49. Seroconversion rates and measles antibody titers induced by measles vaccine in Latin American children 6-12 months of age. Collaborative Study by the Ministries of Health of Brazil, Chile, Costa Rica, Ecuador, and the Pan American Health Organization.
    Bull Pan Am Health Organ; 1982; 16(3):272-85. PubMed ID: 7171892
    [No Abstract]   [Full Text] [Related]  

  • 50. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection.
    Brunell PA; Vimal V; Sandu M; Courville TM; Daar E; Israele V
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):540-8. PubMed ID: 8548333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 52. Low antibody response in infants with measles and children with subclinical measles virus infection.
    Cherian T; Joseph A; John TJ
    J Trop Med Hyg; 1984 Feb; 87(1):27-31. PubMed ID: 6716539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 54. Maternally derived measles immunity in children of naturally infected and vaccinated mothers.
    Jenks PJ; Caul EO; Roome AP
    Epidemiol Infect; 1988 Oct; 101(2):473-6. PubMed ID: 3053223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Measles morbidity among children inoculated against this infection].
    Bolotovskiĭ VM; Gelikman BG; Mikheev IV; Titova NS; Kikosh GV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):38-43. PubMed ID: 3705811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anti-measles humoral immunity in children with thymus hyperplasia].
    Gurvich EB; Lysenkova NV; Shishatskaia SN; Vaganov PD; Ozeretskovskiĭ NA
    Pediatriia; 1989; (9):31-3. PubMed ID: 2587164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Letter: Measles immunity and revaccination.
    Balfour HH; Quie PG; Kalis JM
    JAMA; 1976 May; 235(19):2079. PubMed ID: 946524
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunological study on measles in the Health Demonstration Area of Talavera de la Reina (Toledo)].
    del Pozo Sarompas F
    Rev Sanid Hig Publica (Madr); 1979; 53(1-2):57-71. PubMed ID: 262681
    [No Abstract]   [Full Text] [Related]  

  • 59. [The immune status of children in foci of measles infection studied by an immunoenzyme method].
    Iuminova NV; Unanov SS; Krasnova VP; Malancheva OA; Kovaleva LG; Liashenko VA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):35-8. PubMed ID: 2239001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals.
    Isa MB; Martínez L; Giordano M; Passeggi C; de Wolff MC; Nates S
    Clin Diagn Lab Immunol; 2002 May; 9(3):693-7. PubMed ID: 11986279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.